Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Letters in Applied Microbiology|August 9, 2003
Detection of Escherichia coli serogroups O26, O103, O111 and O145 from bovine faeces using immunomagnetic separation and PCR/DNA probe techniquesC Jenkins, M C Pearce, A W Smith, et al.
Science (New York, N.Y.)|May 8, 2001
Vital involvement of a natural killer cell activation receptor in resistance to viral infectionM G Brown, A O Dokun, J W Heusel, et al.
Communicable Disease and Public Health|July 14, 1999
A study of infectious intestinal disease in England: microbiological findings in cases and controlsD S Tompkins, M J Hudson, H R Smith, et al.
Applied and Environmental Microbiology|March 10, 2004
Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their damsM C Pearce, C Jenkins, L Vali, et al.
HIV Medicine|July 14, 2005
Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapyM R Boulassel, G H R Smith, M D de B Edwardes, et al.
Communicable Disease and Public Health|February 5, 2003
Collaborative investigation of an outbreak of Salmonella enterica serotype Newport in England and Wales in 2001 associated with ready-to-eat salad vegetablesL R Ward, C Maguire, M D Hampton, et al.
The Lancet. Infectious Diseases|July 24, 2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trialDavid A Margolis, Cynthia C Brinson, Graham H R Smith, et al.
Open Forum Infectious Diseases|September 24, 2021
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 StudyGraham H R Smith, W Keith Henry, Daniel Podzamczer, et al.
AIDS (London, England)|November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE TrialMarissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
Pageof 21